Work

Supplemental Figure S3 from Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma

Year: 2024

Type: supplementary-materials

Abstract: Overall Survival by Exosome (50-120nm N=24) Concentration Relative Change (< -0.01, > -0.01): p=0.57 [<-0.01: median=8.9, 95% CI 5.1 to 17.5, >-0.01: median=8.3 95% CI 4.0, 14.1]

DOI: 10.1158/1078-0432.27031033.v1

Authors: William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand. Pathuri, Vinu Madhusudanannair Kunnuparampil, John Floyd, Andrew Brenner

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402819563

Cites:

Cited by:

Related to: 10